Publication | Open Access

Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer

Intratumoral AdministrationOncologyPancreatic CancerGastrointestinal OncologyPreliminary Efficacy StudyPathologyPhase 1/2ACancer TreatmentMedicineRadiation Oncology